Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the Phase 3 OCARINA II Study

Neurology. 2025 Aug 12;105(3):e213909. doi: 10.1212/WNL.0000000000213909. Epub 2025 Jul 2.

Authors

Scott D Newsome, Ewa Krzystanek, Krzysztof W Selmaj, Michal Dufek, Lawrence Goldstick, Carlo Pozzilli, Catarina Figueiredo, Ben Townsend, Heidemarie Kletzl, Oscar Bortolami, Dusanka Zecevic, Caroline Giacobino, Susanne Clinch, Yun-An Shen, Gurpreet Deol Bhullar, Hans-Martin Schneble, Diego Centonze

No abstract available

Publication types

Published Erratum